Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
therapeutics publishing date : 2021 - 09 - 02 save search
Therapeutics MD Is Urging Women to ‘Take Pause’ During Menopause Awareness Month
Published: 2021-09-02 (Crawled : 18:00) - ir.therapeuticsmd.com
TXMD | News | $1.875 -0.27% -0.27% 21K
|
Health Technology
|
| O: 0.24%
H: 7.53%
C: 7.46%
women
Voyager Therapeutics to Participate in Upcoming Investor Conferences
Published: 2021-09-02 (Crawled : 22:00) - globenewswire.com
MS | News 0 d | $93.76 1.81% 0.12% 6.4M
|
Finance
|
| O: -0.33%
H: 0.0%
C: 0.0%
VYGR | News | $7.645 0.99% 0.98% 370K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -7.5%
conference therapeutics
Fate Therapeutics to Present at Upcoming Investor Conferences
Published: 2021-09-02 (Crawled : 20:00) - globenewswire.com
MS | News 0 d | $93.76 1.81% 0.12% 6.4M
|
Finance
|
| O: -0.33%
H: 0.0%
C: 0.0%
FATE | News | $4.54 -5.02% -5.29% 4M
|
Health Technology
|
| O: -0.25%
H: 0.56%
C: -3.09%
conference therapeutics
Larimar Therapeutics to Present at the Morgan Stanley 19th Annual Global Healthcare Conference
Published: 2021-09-02 (Crawled : 20:00) - globenewswire.com
MS | News 0 d | $93.76 1.81% 0.12% 6.4M
|
Finance
|
| O: -0.33%
H: 0.0%
C: 0.0%
LRMR | $6.47 1.09% 1.08% 240K
|
Health Technology
|
| O: -0.46%
H: 0.0%
C: -1.66%
conference
Civetta Therapeutics Announces the Appointment of Christopher D. Roberts, Ph.D., as CEO
Published: 2021-09-02 (Crawled : 18:00) - biospace.com/
SYRS | $5.17 3.61% 3.48% 170K
|
Health Technology
|
| O: -1.6%
H: 6.22%
C: 6.22%
ceo
P-PSMA-101 is a High-Tscm Autologous CAR-T Targeting PSMA Producing Exceptionally Deep and Durable Responses in Castration-Resistant Metastatic Prostate Cancer (mCRPC)
Published: 2021-09-02 (Crawled : 16:00) - poseida.com
PSTX | $2.15 -0.23% -0.23% 420K
|
Health Technology
|
| O: 3.27%
H: 0.0%
C: -4.98%
prostate cancer car-t cancer
mRNA Emerges as the Newest & Most Potent Technology in Medicine. Market to Witness Robust Growth Far Beyond the COVID-19 Pandemic
Published: 2021-09-02 (Crawled : 16:00) - prnewswire.com
TBIO | $0.32 1.52% 1.5% 140K
|
Health Technology
|
| O: 0.05%
H: 0.69%
C: 0.29%
SGMO | News | $0.5212 2.18% 2.13% 2.3M
|
Health Technology
|
| O: 0.68%
H: 0.78%
C: 0.49%
MRNA | News S | $107.87 3.26% 3.16% 2.4M
|
Health Technology
|
| O: 0.82%
H: 2.46%
C: 1.15%
covid growth technology merge
Sorrento Announces Enrollment of First Subject in Brazil Phase 2 Study of COVI-MSC for Treatment of COVID-19 Associated Acute Respiratory Distress in ICU Patients
Published: 2021-09-02 (Crawled : 16:00) - globenewswire.com
SRNE | $0.015 -8.85% 140K
|
Health Technology
|
| O: 0.22%
H: 1.42%
C: -0.11%
covid treatment phase 2 brazil respiratory enroll
MindMed and BioXcel Therapeutics Publish an International Patent Application Describing a System for Identifying Agitation Episodes
Published: 2021-09-02 (Crawled : 14:15) - biospace.com/
MNMD | $8.885 2.36% 2.31% 1.2M
|
n/a
|
| O: 0.0%
H: 3.14%
C: 2.79%
BTAI | News | $2.965 4.04% 3.88% 410K
|
Health Technology
|
| O: 0.27%
H: 2.58%
C: 1.75%
patent application
Global Roundup: VectivBio Acquires Comet Therapeutics to Expand Rare Disease Pipeline
Published: 2021-09-02 (Crawled : 14:00) - biospace.com/
VECT | $16.85 0.12% 130K
|
Professional, Scientific, and T...
|
| O: -0.48%
H: 3.28%
C: -3.28%
IMMP | $2.53 9.05% 8.3% 72K
|
Health Technology
|
| O: -0.49%
H: 4.69%
C: 3.95%
ACIU | $2.38 -1.65% -1.68% 190K
|
Health Technology
|
| O: 0.14%
H: 0.82%
C: -2.33%
disease rare
Scopus BioPharma Launches Duet Therapeutics
Published: 2021-09-02 (Crawled : 14:00) - biospace.com/
SCPS | $0.1682
|
|
| O: 15.07%
H: 25.76%
C: 4.94%
biopharma therapeutics
Global Roundup: VectivBio Acquires Comet Therapeutics to Expand Rare Disease ...
Published: 2021-09-02 (Crawled : 14:00) - biospace.com/
VECT | $16.85 0.12% 130K
|
Professional, Scientific, and T...
|
| O: -0.48%
H: 3.28%
C: -3.28%
IMMP | $2.53 9.05% 8.3% 72K
|
Health Technology
|
| O: -0.49%
H: 4.69%
C: 3.95%
ACIU | $2.38 -1.65% -1.68% 190K
|
Health Technology
|
| O: 0.14%
H: 0.82%
C: -2.33%
disease therapeutics rare
TCR² Therapeutics Receives FDA Orphan Drug Designation for Gavo-cel for the Treatment of Cholangiocarcinoma
Published: 2021-09-02 (Crawled : 14:00) - globenewswire.com
TCRR 4 | $1.48 3.38% 3.9M
|
Health Technology
|
| O: 2.17%
H: 1.28%
C: -0.78%
treatment fda drug cel designation
Better For You Wellness Appoints Montel Williams, Leslie Bumgarner, Joseph Watson, David Deming, and Dr. Nicola Finley, MD to its Board of Directors
Published: 2021-09-02 (Crawled : 14:00) - globenewswire.com
SRNE | $0.015 -8.85% 140K
|
Health Technology
|
| O: 0.22%
H: 1.42%
C: -0.11%
HSDT | $4.88 -3.84% -4.0% 3.9K
|
Health Technology
|
| O: -0.11%
H: 5.11%
C: 4.68%
Atossa Therapeutics Receives Approval from the Swedish Ethics Review Authority to Initiate a Phase 2 Clinical Study of Oral Endoxifen to Reduce Mammographic Breast Density in Sweden
Published: 2021-09-02 (Crawled : 14:00) - globenewswire.com
ATOS | $1.485 4.58% 4.38% 1.1M
|
Health Technology
|
| O: 0.27%
H: 14.33%
C: 0.8%
phase 2 approval authorized
Developing piggyBac Systems “Off-the-Shelf” CAR-T Cells for Bone Marrow Transplant Conditioning
Published: 2021-09-02 (Crawled : 13:00) - poseida.com
PSTX | $2.15 -0.23% -0.23% 420K
|
Health Technology
|
| O: 3.27%
H: 0.0%
C: -4.98%
bone car-t t-cell
Capricor Therapeutics to Present Final Data from HOPE-2 Trial with CAP-1002 in Duchenne Muscular Dystrophy at World Muscle Society 2021
Published: 2021-09-02 (Crawled : 13:00) - globenewswire.com
CAPR | $4.81 -2.63% -2.7% 480K
|
Health Technology
|
| O: 2.6%
H: 4.85%
C: 2.95%
trial cap-1002 duchenne
Autolus Therapeutics to participate in upcoming virtual investor conferences
Published: 2021-09-02 (Crawled : 12:15) - biospace.com/
AUTL | $4.5 -1.32% -1.33% 1.7M
|
Health Technology
|
| O: 1.82%
H: 3.71%
C: 1.24%
conference therapeutics
Seelos Therapeutics Announces Appointment of Margaret Dalesandro to the Board of Directors
Published: 2021-09-02 (Crawled : 12:00) - prnewswire.com
GSK | News | $41.24 1.6% 0.0% 2.3M
|
Health Technology
|
| O: 0.07%
H: 0.83%
C: 0.7%
LLY | News | $745.69 1.96% -0.16% 2M
|
Health Technology
|
| O: 0.0%
H: 0.9%
C: 0.84%
SEEL | $0.326 0.09% 0.09% 380K
|
Health Technology
|
| O: 1.78%
H: 1.66%
C: -3.11%
ONCS | $0.2772 25.59% 52M
|
Health Services
|
| O: -0.85%
H: 2.16%
C: 0.0%
Plus Therapeutics Announces Commercial Manufacturing Supply Agreement for Its Lead Investigational Drug
Published: 2021-09-02 (Crawled : 12:00) - biospace.com/
PSTV | News | $1.65 -0.6% -0.61% 17K
|
Health Technology
|
| O: 18.42%
H: 2.22%
C: -8.89%
drug commercialization
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.